Looking above but not beyond the genome for therapeutics in neurology and psychiatry
We welcome you to a special issue of Neurotherapeutics that highlights much of the exciting new thinking behind a burgeoning and therapeutically relevant topic—epigenetic proteins in psychiatric and neurological disease. It is now well established that expression of single genes or gene cassettes is...
محفوظ في:
| المؤلف الرئيسي: | |
|---|---|
| مؤلفون آخرون: | , |
| التنسيق: | article |
| منشور في: |
2013
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/10725/6134 http://dx.doi.org/10.1007/s13311-013-0225-2 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://link.springer.com/content/pdf/10.1007%2Fs13311-013-0225-2.pdf |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
| الملخص: | We welcome you to a special issue of Neurotherapeutics that highlights much of the exciting new thinking behind a burgeoning and therapeutically relevant topic—epigenetic proteins in psychiatric and neurological disease. It is now well established that expression of single genes or gene cassettes is determined by the interplay between transcription factors and epigenetic modulators. Epigenetics literally means “above the genome” and is defined by modifications of DNA, as well as chromatin that ultimately affect gene expression. Accordingly, epigenetic markers can be considered similar to punctuation marks in the English language. They define the beginning and the end of a gene; they structure the chromosomes; and they alter how the information is read, either activating or silencing transcription. |
|---|